Edwards Lifesciences v Meril Life Sciences (CFI, ORD_16663/2024, 20 August 2024)
| Date | 20 August 2024 |
|---|---|
| Court | CFI |
| Division | Nordic Baltic Regional Division |
| Type of action | Generic application |
| Registry reference | App_14299/2024 · ORD_16663/2024 |
| Parties | MERIL LIFE SCIENCES PVT LIMITED, INTERLUX, UAB, SMIS INTERNATIONAL OÜ, MERIL GMBH, SORMEDICA, UAB, VAB-LOGISTIK, UAB |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 20 August 2024 (UPC_CFI_380/2023, ACT_582093/2023, ORD_16663/2024), the Nordic-Baltic Regional Division (Johansson, Härmand, Bessaud, Wilhelm) dismissed the request of Meril Life Sciences and five other defendants to stay the infringement action on EP 3 769 722 brought by Edwards Lifesciences pending the decision of the EPO Opposition Division. Leave to appeal was granted.
Question
Should the division stay proceedings during an EPO opposition, on the basis of Rule 118.2(b) RoP, Art. 33(10) UPCA or Rule 295 RoP?
Decision
No. Rule 118.2(b) RoP, located in the chapter on the oral procedure, cannot found a stay during the written procedure (paragraphs 4 to 6). The primary provisions are Art. 33(10) UPCA and Rule 295(a) RoP, which require that a rapid EPO decision be expected (paragraph 7). That is not so: the opposition was filed on 7 March 2024 and the Opposition Division’s decision would probably be appealed, adding 18 to 24 months (paragraph 8). Rule 295(m) RoP must respect those specific provisions and the right to a hearing within a reasonable time (paragraphs 9 to 11). As a rule, the division will not stay where a final EPO decision is not expected rapidly, even if invalidity is highly likely (paragraph 12), all the more so as the UPC will itself decide the counterclaims for revocation (paragraph 13). The auxiliary request under Art. 33(3) UPCA is dismissed, as no bifurcation is envisaged (paragraph 16).
Key points for practice
- Practical point: a recent EPO opposition is not enough to obtain a stay, the defendant must show that a final decision can be expected rapidly.
Provisions applied
- Agreement on a Unified Patent Court
- Arts. 33(3) and (10) and 73(2)(b)(ii)
- Rules of Procedure
- Rules 37, 118.2(b), 220.2, 224.1(b) and 295
- Case law cited
- Carrier v BITZER Electronics, Court of Appeal, 28 May 2024
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantMERIL GMBH45 decisions in the corpusFollow this party
- claimantMERIL LIFE SCIENCES PVT LIMITED8 decisions in the corpusFollow this party
- claimantSMIS INTERNATIONAL OÜ7 decisions in the corpusFollow this party
- claimantSORMEDICA7 decisions in the corpusFollow this party
- claimantUAB7 decisions in the corpusFollow this party
- claimantINTERLUX5 decisions in the corpusFollow this party
- claimantVAB-LOGISTIK6 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Generic application
- Outcome (Dhenne Avocats summary)
- La demande de sursis à statuer dans l'attente de la décision de la division d'opposition de l'OEB est rejetée, aucune décision définitive rapide n'étant attendue. L'appel est autorisé.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 769 722mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Edwards Lifesciences v Meril Life Sciences (CFI, ORD_14940/2024, 20 August 2024) cited in this record
- Carrier v BITZER Electronics (CoA, 28 May 2024) cited in this record
Patents and standards
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.